Нарушения углеводного обмена и синдром обструктивного апноэ во сне


Цитировать

Полный текст

Аннотация

Аннотация. Анализируется взаимосвязь синдрома обструктивного апноэ во сне (СОАС) и нарушений углеводного обмена. Представлены данные клинических исследований, в которых СОАС рассматривается как фактор риска развития сахарного диабета 2-го типа (СД2). Приведен анализ наиболее значимых факторов, влияющих на прогрессирование нарушений углеводного обмена у пациентов с СОАС. Рассматривается возможность коррекции СОАС у больных СД2 в качестве модифицируемого фактора риска.

Полный текст

Нарушения углеводного обмена и синдром обструктивного апноэ во сне. - Аннотация. Анализируется взаимосвязь синдрома обструктивного апноэ во сне (СОАС) и нарушений углеводного обмена. Представлены данные клинических исследований, в которых СОАС рассматривается как фактор риска развития сахарного диабета 2-го типа (СД2). Приведен анализ наиболее значимых факторов, влияющих на прогрессирование нарушений углеводного обмена у пациентов с СОАС. Рассматривается возможность коррекции СОАС у больных СД2 в качестве модифицируемого фактора риска.
×

Об авторах

В Э Олейников

Медицинский институт Пензенского государственного университета

Email: oleynikoff@sura.ru

Н В Сергацкая

Медицинский институт Пензенского государственного университета

Список литературы

  1. Рунихин А.Ю., Новикова Ю.В. Современные аспекты патогенеза и лечения сахарного диабета 2 типа. Рус мед журн 2007; 27: 2060-2065.
  2. Resnick H.E., Redline S., Shahar E. et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003; 26: 702-709.
  3. Бузунов Р.В. Синдром обструктивного апноэ сна в сочетании с ожирением: особенности патогенеза, диагностики и лечения: Дис. ... д-ра мед. наук. М 2003; 208.
  4. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respirat Critical Care Med 2002; 165 (9): 1217-1239.
  5. Manser R.M., Rochford P., Pierce R.J. et al. Impact for defining hypopneas in the Panea-Hypopnea Index. Chest 2001; 120: 909-914.
  6. Knutson K.L., Spiegel K., Penev P., Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11 (3): 163-178.
  7. Marin J.M., Carrizo S.J., Vicente E. et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
  8. Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.
  9. Einhorn D., Stewart D.A., Erman M.K. et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007; 13: 355-362.
  10. Marshall N., Keith K., Wong M. et al. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton study? J Clin Sleep Med 2009; 5 (1): 15-20.
  11. Roncksley P.E., Hemmelgarn B.R., Heitman S.J. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009; 64: 834-839.
  12. West S.D., Nicoll D.J., Wallace T.M. et al. Obstructive sleep apnea in men with type 2 diabetes: a double blind randomized controlled trial of the effects of CPAP on HbA1c and insulin resistance [abstract]. Paper presented at: the American Thoracic Society Meeting; May 19-24, 2006; San Diego, CA.
  13. Foster G.E., Kuna S.T., Sanders M.H. et al. Sleep apnea in obese adults with type 2 diabetes: baseline results from sleep AHEAD study [abstract]. Sleep 2005; 25: 066.
  14. Tsai W.H. Obstructive sleep apnea is associated with diabetes in sleepy subjects. Thorax 2009; 64 (10): 834-839.
  15. Reichmuth K.J., Austin D., Skatrud J.B. et al. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172: 1590-1598.
  16. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.
  17. Young T., Palta M., Dempsey J. et al. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328 (17): 1230-1235.
  18. Bixler E.O., Vgontzas A.N., Lin H.-M. et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Critical Care Med 2001; 163 (3.1): 608-613.
  19. Redline S., Kump K., Tishler P.V. et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Critical Care Med 1994; 149 (3.1): 722-726.
  20. Newman A.B., Nieto F.J., Guidry U. et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 1995; 154 (1): 50-59.
  21. Young T., Shahar E., Nieto F.J. et al. Predictors of sleepdisordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162 (8): 893-900.
  22. Bixler E.O., Vgontzas A.N., Ten Have T. et al. Effects of age on sleep apnea in men. Prevalence and severity. Am J Respir Critical Care Med 1998; 157 (1): 144-148.
  23. Duran J., Esnaola S., Rubio R., Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Critical Care Med 2001; 163 (3.1): 685-689.
  24. Redline S., Tishler P.V., Hans M.G. et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Critical Care Med 1997; 155(1): 186-192.
  25. Surani S., Aguillar R., Komari V. et al. Influence of Hispanic ethnicity in prevalence of diabetes mellitus on sleep apnea and relationship to sleep phase. Postgraduate Med 2009; 121 (15): 108-112.
  26. Punjabi N.M., Sorkin J.D., Katzel L.I. et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Critical Care Med 2002; 165 (5): 677-682.
  27. Guilleminault C., Bassiri A., Caskadon M.A. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and upper airway resistance syndrome. In: Kryger M.H., Roth T., Dement W.C. (eds) Principles and Practice of Sleep Medicine, 2nd ed. Philadelphia: Elsevier Saunders 2005: 1043-1052.
  28. Bliwise D.L., Feldman D.E., Bliwise N.G. et al. Risk factor for sleep disordered breathing in heterogeneous geriatric populations. J Am Geriatr Society 1987; 35 (2): 132-141.
  29. Foster G.E., Sanders M.H., Millman R. et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009; 32 (6): 1017-1039.
  30. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Applied Physiol 2005; 99 (5): 1998-2007.
  31. Punjabi N.M., Shahar E., Redline S. et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6): 521-530.
  32. Harsch I.A., Schahin S.P., Radespiel-Troger M. et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162.
  33. Elmasry A., Janson C., Lindberg E. et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001; 249 (2): 153-161.
  34. Ip M.S.M., Lam B., Ng M.M.T. et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Critical Care Med 2002; 165 (5): 670-676.
  35. Meslier N., Gagnadoux F., Giraud P. et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003; 22: 156-160.
  36. Somers V.K., Dyken M.E., Clary M.P., Abbound F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904.
  37. Polotsky V.Y., Li J., Punjabi N.M. et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (1): 253-264.
  38. Botros N., Concato J., Mohsenin V. et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009; 122 (12): 1122-1127.
  39. Shin C., Kim J. et al. Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men. Am J Respir Crit Care Med 2005; 171: 287-291.
  40. Joo S., Lee S., Choi H.A. et al. Habitual snoring is associated with elevated hemoglobin A1c levels in non-obese middle-aged adults. J Sleep Res 2006; 15: 437-444.
  41. Peltier A.C., Consens F.B., Sheikh K. et al. Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med 2007; 8: 149-155.
  42. Kono M., Tatsumi K., Saibara T. et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007; 131: 1387-1392.
  43. Shaw J.E., Punjabi N.M., Wilding J.P. et al. Sleep-disordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008; 81: 2-12.
  44. Oltmanns K.M., Gehring H., Rudolf S. et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004; 169: 1231-1237.
  45. Cutler M.J., Swift N.M., Keller D.M. et al. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 2004; 96: 754-761.
  46. Mallon L., Broman J.E., Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005; 28: 2762-2767.
  47. Yaggi K., Araujo A., McKinlay J. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29: 657-661.
  48. Tasali E., Ip M.S.M. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008; 5 (2): 207-217.
  49. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008; 133 (2): 496-506.
  50. Coughlin S.R., Mawdsley L., Mugarza J.A. et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9): 735-741.
  51. Levy P., Bonsignore M.R., Eckel J. Sleep, sleepdisordered breathing andmetabolic consequences. Eur Respirat J 2009; 34 (1): 243-260.
  52. Makino S., Handa H., Suzukawa K. et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64: 12-19.
  53. Davies R., Turner R., Crosby J. et al. Plasma insulin and lipid levels in untreated obstructive sleep apnea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 1994; 3: 180-185.
  54. Gruber A., Horwood F., Sithole J. et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22.
  55. Sharma S.K., Kumpawat S., Goel A. et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007; 8: 12-17.
  56. Vgontzas A.N., Legro R.S., Bixler E.O. et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metabol 2001; 86 (2): 517-520.
  57. Theorell-Haglow J., Berne C., Janson C., Lindberg E. Obstructive sleep apnoea is associated with decreased insulin sensitivity in females. Eur Respir J 2008; 31: 1054-1060.
  58. Manzella D., Parillo M., Razzino T. et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Intern J Obes 2002; 26 (3): 370-375.
  59. Zhang L.Q., Yao W.Z., Wang Y.Z. et al. Relationship between obstructive sleep apnea/hypopnea syndrome and insulin resistance. Zhonghua Nei Ke Za Zhi 2006; 45 (3): 184-187.
  60. Leproult R., Copinschi G., Buxton O., Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997; 20 (10): 865-870.
  61. Strohl K.P. Diabetes and sleep apnea. Sleep 1996; 19: S225-S228.
  62. Ip M.S.M. Obstructive sleep apnoea, insulin resistance and sleepiness. Thorax 2008; 63: 939-940.
  63. Barcelo A., Barbe F., de la Pena M. et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax 2008; 63: 946-950.
  64. Spiegel K., Leproult R., Van Cauter E. Impact of sleep debt on metabolic and endocrine function. The Lancet 1999; 354 (9188): 1435-1439.
  65. Bopparaju S., Surani S. Sleep and Diabetes. Review article. Intern J Endocrinol 2010; 2010: 1-9.
  66. Kruszynska Y.T., Worrall D.S., Ofrecio J. et al. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 2002; 87 (1): 226-234.
  67. Nieto F.J., Young T.B., Lind B.K. et al. Association of sleep-disordered breathing sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14): 1829-1836.
  68. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15 (11): 2792-2800.
  69. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
  70. Zhan G., Serrano F., Fenik P. et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005; 172: 921-929.
  71. Furukawa S., Fujita T., Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
  72. Laight D.W., Desai K.M., Gopaul N.K. et al. Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat. Br J Pharmacol 1999; 128: 269-271.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2012

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Адрес издателя

  • 127055, г. Москва, Алабяна ул., 13, корп.1

Адрес редакции

  • 127055, г. Москва, Алабяна ул., 13, корп.1

По вопросам публикаций

  • +7 (926) 905-41-26
  • editor@ter-arkhiv.ru

По вопросам рекламы

  • +7 (495) 098-03-59

 

  


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах